Enhanced Recovery After Surgery (ERAS)Guidelines in Mitral Valve Surgeries, Questionnaire

ERAS Clinical Trial

Official title:

Enhanced Recovery After Surgey (ERAS)Guidelines in Mitral Valve Surgeries, Questionnaire

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05617768
• Other study ID #: MS-337-2022
• Status: Recruiting
• Start date: November 20, 2022
• Est. completion date: November 1, 2023

Study information

• Verified date: August 2023
• Source: Cairo University
• Contact: sherif M Abbas, MD.
• Phone: 0201141235049
• Email: s25041989[@]hotmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

ERAS after cardiac surgery is a well known protocol ,However the investigators study if it is applied at our institute

Description:

Enhanced recovery after surgery (ERAS) is a term that include a series of evidence-based perioperative care pathways designed to reduce physiological and psychological stress in surgical patients and to achieve rapid recovery. In 2016, the first pilot study was published, which analyzed enhanced recovery after cardiac surgery (ERACS). Weaning from mechanical ventilation is considered one of the items that forms the concept of enhanced recovery in cardiac surgery. Pain is an undesirable consequence of surgery especially cardiac surgery as pain during and following cardiac surgery has been shown to be a risk factor for increased morbidity. Systemic opioids have been the main stay for the management of perioperative pain in cardiac surgery. Lower doses of opioids has been related to early extubation and minimizing opioid-related side effects, such as prolonged ventilation, tolerance, nausea, vomiting, gut dysfunction, and immunosuppression. On the other hand the investigators find cases of morbidity and mortality not related to the surgical procedure. ERAS protocol discuss the optimum condition that can be used to avoid the morbidity and mortality complications. the investigators aim to know how well ERAS protocol is known and applied

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 267
• Est. completion date: November 1, 2023
• Est. primary completion date: October 1, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 25 Years to 60 Years

Eligibility

Inclusion Criteria:

• Cardiac anesthesiologists.
• Cardiac intensivists.
• Cardiothoracic surgeons.
• All stuff members from resident to consultant are included inside this study Exclusion Criteria: -

Related Conditions & MeSH terms

• ERAS

Locations

Country	Name	City	State
Egypt	Cairo Unviersity	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Assessement of the knowledge of doctors to ERAS guidelines in cardiac surgery by using the grading system.	Assessement of the knowledge of doctors to ERAS guidelines in cardiac surgery by using the grading system.Grading system will be described as:-; Grade A ( knows well( : more than 60 % correct answer; Grade B ( fair ): 35 :60 % correct answer; Grade C ( knows nothing ) :- less than 35 % correct answer	6 months